Home / EGRX : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does EGRX make money? Does EGRX have pricing power? What's the Earnings Whisper? Will EGRX profit more as the business scales? What is EGRX's management track record? Is EGRX's current price justified?

Eagle Pharmaceuticals, Inc.

$0.5 +$0.16 (+47.06%)

OTC · 11 Sep 2026 19:47 UTC

Previous Close

$0.76

Day Range

$0.5$0.74

Year Range

$0.05$3.87

Market Cap

6.58M

AVG Volume

4.75K

Trailing/Forward PE

0.18/-

PEG ratio

-0.01

Dividend Yield

Next Earnings Date

2026-11-09

Primary Exchange

Other OTC

Revenue (USD)

EGRX Revenue (USD) by quarter
Period	Revenue (USD)
23 Q2	64.65M
23 Q1	66.31M
22 Q4	60.7M
22 Q3	65.9M
22 Q2	74.14M
22 Q1	115.87M
21 Q4	42.32M
21 Q3	39.85M
21 Q2	48.12M
21 Q1	41.25M

Net Income (USD)

EGRX Net Income (USD) by quarter
Period	Net Income (USD)
23 Q2	5.16M
23 Q1	5.75M
22 Q4	8.16M
22 Q3	-3.51M
22 Q2	-9.45M
22 Q1	44.06M
21 Q4	-6.2M
21 Q3	-5.62M
21 Q2	3.61M
21 Q1	-421K

Operating Income (USD)

EGRX Operating Income (USD) by quarter
Period	Operating Income (USD)
23 Q2	10.3M
23 Q1	6.19M
22 Q4	9.47M
22 Q3	-2.31M
22 Q2	2.2M
22 Q1	59.83M
21 Q4	5.9M
21 Q3	-10.18M
21 Q2	10.82M
21 Q1	-3.77M

EBITDA (USD)

EGRX EBITDA (USD) by quarter
Period	EBITDA (USD)
23 Q2	16.33M
23 Q1	17.31M
22 Q4	21.19M
22 Q3	2.15M
22 Q2	2.2M
22 Q1	58.93M
21 Q4	2.69M
21 Q3	-10.18M
21 Q2	6.86M
21 Q1	2.66M

Cash Flows (USD)

EGRX Cash Flows (USD) by quarter
Period	Cash Flows (USD)
23 Q2	-132K
23 Q1	-33.57M
22 Q4	37.55M
22 Q3	-13.24M
22 Q2	42.99M
22 Q1	-16.78M
21 Q4	8.03M
21 Q3	1.06M
21 Q2	8.71M
21 Q1	10.09M

EPS (USD)

EGRX EPS (USD) by quarter
Period	EPS (USD)
23 Q2	0.39
23 Q1	0.44
22 Q4	0.62
22 Q3	-0.27
22 Q2	-0.74
22 Q1	3.41
21 Q4	-0.48
21 Q3	-0.43
21 Q2	0.27
21 Q1	-0.03

Expenses (USD)

EGRX Expenses (USD) by quarter
Period	Expenses (USD)
23 Q2	37.49M
23 Q1	37.29M
22 Q4	31.38M
22 Q3	32.79M
22 Q2	48.27M
22 Q1	28.46M
21 Q4	24.16M
21 Q3	41.78M
21 Q2	26.43M
21 Q1	34.55M

Cash & Debt (USD)

EGRX Cash & Debt (USD) by quarter
Period	Cash & Debt (USD)
23 Q2	15.35M
23 Q1	21.9M
22 Q4	55.32M
22 Q3	15.38M
22 Q2	36.56M
22 Q1	69.52M
21 Q4	97.66M
21 Q3	99.74M
21 Q2	108.72M
21 Q1	105.23M

Debt ratios

EGRX Debt ratios by quarter
Period	Debt ratios
23 Q2	0.99
23 Q1	1.27
22 Q4	0.08
22 Q3	0.7
22 Q2	0.32
22 Q1	-0.72
21 Q4	-35.48
21 Q3	-5.54
21 Q2	-2.29
21 Q1	-2.1

Margins

EGRX Margins by quarter
Period	Margins
23 Q2	73.92%
23 Q1	73.91%
22 Q4	67.27%
22 Q3	64.11%
22 Q2	68.08%
22 Q1	76.05%
21 Q4	70.91%
21 Q3	79.28%
21 Q2	77.65%
21 Q1	73.68%

Return on Capital

EGRX Return on Capital by quarter
Period	Return on Capital
23 Q2	2.05%
23 Q1	2.37%
22 Q4	3.5%
22 Q3	-1.49%
22 Q2	-3.97%
22 Q1	20.4%
21 Q4	-3.51%
21 Q3	-3.03%
21 Q2	1.85%
21 Q1	-0.22%

Shares Outstanding

EGRX Shares Outstanding by quarter
Period	Shares Outstanding
23 Q2	13.09M
23 Q1	13.06M
22 Q4	13.02M
22 Q3	13.17M
22 Q2	12.84M
22 Q1	12.71M
21 Q4	12.9M
21 Q3	13.07M
21 Q2	13.11M
21 Q1	13.07M

Book Value Per Share (USD)

EGRX Book Value Per Share (USD) by quarter
Period	Book Value Per Share (USD)
23 Q2	19.25
23 Q1	18.6
22 Q4	17.94
22 Q3	17.88
22 Q2	18.54
22 Q1	16.99
21 Q4	13.68
21 Q3	14.17
21 Q2	14.86
21 Q1	14.62

Total Assets (USD)

EGRX Total Assets (USD) by quarter
Period	Total Assets (USD)
23 Q2	404.82M
23 Q1	414.18M
22 Q4	406.16M
22 Q3	390.07M
22 Q2	381.76M
22 Q1	320.17M
21 Q4	253.73M
21 Q3	256.26M
21 Q2	264.24M
21 Q1	259.97M

Employee Count

EGRX Employee Count by quarter
Period	Employee Count
2022	134
2021	102
2020	106
2019	108
2018	96
2017	108
2016	77
2015	41
2014	28

PE Ratio

EGRX PE Ratio by quarter
Period	PE Ratio
Sep 26	0.14
Sep 26	0.63
Aug 26	0.78
Aug 26	0.45
Aug 26	0.5
Aug 26	0.04
Jul 26	0.31
Jul 26	0.31
Jul 26	0.5
Jul 26	0.56
Jul 26	0.56
Jun 26	0.56
Jun 26	0.52
Jun 26	0.5
Jun 26	0.5
May 26	0.48
May 26	0.32
May 26	0.32
May 26	0.32
May 26	0.4
Apr 26	0.32
Apr 26	0.29
Apr 26	0.29
Apr 26	0.21
Mar 26	0.29
Mar 26	0.07
Mar 26	0.29
Mar 26	0.13
Feb 26	0.13
Feb 26	0.17
Feb 26	0.21
Feb 26	0.21
Jan 26	0.21
Jan 26	0.59
Jan 26	0.42
Jan 26	0.32
Jan 26	0.29
Dec 25	0.28
Dec 25	0.25
Dec 25	0.46
Dec 25	0.59
Nov 25	0.42
Nov 25	0.66
Nov 25	1.09
Nov 25	1.26
Oct 25	0.59
Oct 25	0.84
Oct 25	1.26
Oct 25	1.35
Oct 25	2.52
Sep 25	2.27
Sep 25	2.83
Sep 25	2.7
Sep 25	2.55
Aug 25	2.6
Aug 25	2.68
Aug 25	2.69
Aug 25	2.68
Aug 25	2.68
Jul 25	3.1
Jul 25	3.11
Jul 25	2.99
Jul 25	2.52
Jun 25	2.44
Jun 25	2.42
Jun 25	2.02
Jun 25	1.89
May 25	1.6
May 25	1.68
May 25	1.63
May 25	1.67
May 25	1.66
Apr 25	1.43
Apr 25	1.51
Apr 25	1.01
Apr 25	1.58
Mar 25	0.74
Mar 25	1.25
Mar 25	1.09
Mar 25	0.71
Feb 25	1.01
Feb 25	1.25
Feb 25	0.98
Feb 25	0.76
Jan 25	0.67
Jan 25	0.82
Jan 25	0.55
Jan 25	0.55
Jan 25	0.34
Dec 24	0.42
Dec 24	0.46
Dec 24	0.63
Dec 24	0.71
Nov 24	0.6
Nov 24	0.8
Nov 24	0.55
Nov 24	0.72
Nov 24	0.46
Oct 24	0.5
Oct 24	0.76

Free Cash Flow Yield

EGRX Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-444.79%
Sep 26	-95.66%
Aug 26	-77.56%
Aug 26	-135.37%
Aug 26	-120.58%
Aug 26	-1409.52%
Jul 26	-193.9%
Jul 26	-193.9%
Jul 26	-120.58%
Jul 26	-107.08%
Jul 26	-107.08%
Jun 26	-107.08%
Jun 26	-116.66%
Jun 26	-119.57%
Jun 26	-119.57%
May 26	-124.77%
May 26	-186.35%
May 26	-191.32%
May 26	-188.8%
May 26	-151.04%
Apr 26	-188.8%
Apr 26	-204.99%
Apr 26	-210.4%
Apr 26	-286.92%
Mar 26	-210.4%
Mar 26	-844.06%
Mar 26	-210.4%
Mar 26	-478.3%
Feb 26	-478.3%
Feb 26	-358.72%
Feb 26	-286.98%
Feb 26	-286.98%
Jan 26	-286.98%
Jan 26	-102.49%
Jan 26	-143.49%
Jan 26	-188.8%
Jan 26	-211.01%
Dec 25	-217.41%
Dec 25	-239.15%
Dec 25	-130.45%
Dec 25	-102.49%
Nov 25	-143.49%
Nov 25	-91.98%
Nov 25	-55.19%
Nov 25	-47.83%
Oct 25	-102.49%
Oct 25	-71.74%
Oct 25	-47.83%
Oct 25	-44.84%
Oct 25	-23.91%
Sep 25	-26.57%
Sep 25	-21.29%
Sep 25	-22.35%
Sep 25	-23.68%
Aug 25	-23.22%
Aug 25	-22.49%
Aug 25	-22.42%
Aug 25	-22.49%
Aug 25	-22.49%
Jul 25	-19.44%
Jul 25	-19.39%
Jul 25	-20.21%
Jul 25	-23.91%
Jun 25	-24.74%
Jun 25	-24.91%
Jun 25	-29.89%
Jun 25	-31.89%
May 25	-37.76%
May 25	-35.87%
May 25	-36.98%
May 25	-36.05%
May 25	-36.42%
Apr 25	-42.2%
Apr 25	-39.86%
Apr 25	-59.79%
Apr 25	-38.16%
Mar 25	-81.53%
Mar 25	-48.15%
Mar 25	-55.19%
Mar 25	-84.41%
Feb 25	-59.79%
Feb 25	-48.15%
Feb 25	-61.32%
Feb 25	-79.72%
Jan 25	-89.68%
Jan 25	-73.21%
Jan 25	-110.38%
Jan 25	-110.38%
Jan 25	-174.99%
Dec 24	-143.49%
Dec 24	-130.45%
Dec 24	-95.66%
Dec 24	-84.41%
Nov 24	-101.05%
Nov 24	-75.52%
Nov 24	-110.33%
Nov 24	-84.31%
Nov 24	-130.45%
Oct 24	-119.57%
Oct 24	-79.72%

Price to Sales

EGRX Price to Sales by quarter
Period	Price to Sales
Sep 26	0.01
Sep 26	0.04
Aug 26	0.05
Aug 26	0.03
Aug 26	0.03
Aug 26	0
Jul 26	0.02
Jul 26	0.02
Jul 26	0.03
Jul 26	0.03
Jul 26	0.03
Jun 26	0.03
Jun 26	0.03
Jun 26	0.03
Jun 26	0.03
May 26	0.03
May 26	0.02
May 26	0.02
May 26	0.02
May 26	0.02
Apr 26	0.02
Apr 26	0.02
Apr 26	0.02
Apr 26	0.01
Mar 26	0.02
Mar 26	0
Mar 26	0.02
Mar 26	0.01
Feb 26	0.01
Feb 26	0.01
Feb 26	0.01
Feb 26	0.01
Jan 26	0.01
Jan 26	0.04
Jan 26	0.03
Jan 26	0.02
Jan 26	0.02
Dec 25	0.02
Dec 25	0.02
Dec 25	0.03
Dec 25	0.04
Nov 25	0.03
Nov 25	0.04
Nov 25	0.07
Nov 25	0.08
Oct 25	0.04
Oct 25	0.05
Oct 25	0.08
Oct 25	0.08
Oct 25	0.15
Sep 25	0.14
Sep 25	0.17
Sep 25	0.16
Sep 25	0.15
Aug 25	0.16
Aug 25	0.16
Aug 25	0.16
Aug 25	0.16
Aug 25	0.16
Jul 25	0.19
Jul 25	0.19
Jul 25	0.18
Jul 25	0.15
Jun 25	0.15
Jun 25	0.15
Jun 25	0.12
Jun 25	0.11
May 25	0.1
May 25	0.1
May 25	0.1
May 25	0.1
May 25	0.1
Apr 25	0.09
Apr 25	0.09
Apr 25	0.06
Apr 25	0.1
Mar 25	0.04
Mar 25	0.08
Mar 25	0.07
Mar 25	0.04
Feb 25	0.06
Feb 25	0.08
Feb 25	0.06
Feb 25	0.05
Jan 25	0.04
Jan 25	0.05
Jan 25	0.03
Jan 25	0.03
Jan 25	0.02
Dec 24	0.03
Dec 24	0.03
Dec 24	0.04
Dec 24	0.04
Nov 24	0.04
Nov 24	0.05
Nov 24	0.03
Nov 24	0.04
Nov 24	0.03
Oct 24	0.03
Oct 24	0.05

EV/EBITDA

EGRX EV/EBITDA by quarter
Period	EV/EBITDA
Sep 26	1.02
Sep 26	1.16
Aug 26	1.2
Aug 26	1.11
Aug 26	1.12
Aug 26	1
Jul 26	1.07
Jul 26	1.07
Jul 26	1.12
Jul 26	1.14
Jul 26	1.14
Jun 26	1.14
Jun 26	1.13
Jun 26	1.13
Jun 26	1.13
May 26	1.12
May 26	1.08
May 26	1.07
May 26	1.07
May 26	1.1
Apr 26	1.07
Apr 26	1.07
Apr 26	1.07
Apr 26	1.04
Mar 26	1.07
Mar 26	1.01
Mar 26	1.07
Mar 26	1.02
Feb 26	1.02
Feb 26	1.03
Feb 26	1.04
Feb 26	1.04
Jan 26	1.04
Jan 26	1.15
Jan 26	1.1
Jan 26	1.07
Jan 26	1.07
Dec 25	1.06
Dec 25	1.06
Dec 25	1.11
Dec 25	1.15
Nov 25	1.1
Nov 25	1.17
Nov 25	1.29
Nov 25	1.33
Oct 25	1.15
Oct 25	1.22
Oct 25	1.33
Oct 25	1.35
Oct 25	1.68
Sep 25	1.61
Sep 25	1.76
Sep 25	1.72
Sep 25	1.68
Aug 25	1.7
Aug 25	1.72
Aug 25	1.72
Aug 25	1.72
Aug 25	1.72
Jul 25	1.84
Jul 25	1.84
Jul 25	1.8
Jul 25	1.68
Jun 25	1.65
Jun 25	1.65
Jun 25	1.54
Jun 25	1.5
May 25	1.42
May 25	1.45
May 25	1.43
May 25	1.44
May 25	1.44
Apr 25	1.38
Apr 25	1.4
Apr 25	1.26
Apr 25	1.42
Mar 25	1.19
Mar 25	1.33
Mar 25	1.29
Mar 25	1.18
Feb 25	1.26
Feb 25	1.33
Feb 25	1.26
Feb 25	1.19
Jan 25	1.17
Jan 25	1.21
Jan 25	1.14
Jan 25	1.14
Jan 25	1.08
Dec 24	1.1
Dec 24	1.11
Dec 24	1.16
Dec 24	1.18
Nov 24	1.15
Nov 24	1.21
Nov 24	1.14
Nov 24	1.18
Nov 24	1.11
Oct 24	1.13
Oct 24	1.19

Price/Operating Cashflow

EGRX Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Aug 23	8.32
Jul 23	7.19
Jul 23	7.58
Jul 23	7.1
Jul 23	7.46
Jun 23	7.51
Jun 23	7.95
Jun 23	7.29
Jun 23	7.29
Jun 23	8.32
May 23	7.9
May 23	8.2
May 23	7.96
May 23	7.36
Apr 23	7.21
Apr 23	7.09
Apr 23	7.63
Apr 23	8.18
Mar 23	7.28
Mar 23	6.82
Mar 23	15.94
Mar 23	15.55
Mar 23	16.77
Feb 23	17.88
Feb 23	19.11
Feb 23	19.23
Feb 23	20.79
Jan 23	20.94
Jan 23	21.04
Jan 23	20.13
Jan 23	18.9
Dec 22	18.13
Dec 22	18.06
Dec 22	18.19
Dec 22	19.26
Dec 22	22.28
Nov 22	22.26
Nov 22	23.3
Nov 22	23.33
Nov 22	11.4
Oct 22	11.9
Oct 22	11.05
Oct 22	9.97
Oct 22	9.41
Sep 22	9.55
Sep 22	9.75
Sep 22	10.45
Sep 22	11.31
Sep 22	11.65
Aug 22	12.98
Aug 22	13.66
Aug 22	12.93
Aug 22	484.24
Jul 22	446.56
Jul 22	452.63
Jul 22	504.26
Jul 22	516.86
Jul 22	525.19
Jun 22	476.71
Jun 22	474.34
Jun 22	496.73
Jun 22	532.05
May 22	546.11
May 22	525.41
May 22	494.93
May 22	19.77
Apr 22	20.17
Apr 22	22.12
Apr 22	23.05
Apr 22	23.47
Apr 22	23.44
Mar 22	21.47
Mar 22	22.5
Mar 22	23.19
Mar 22	14.78
Feb 22	15.35
Feb 22	15.13
Feb 22	15.91
Feb 22	14.61
Jan 22	14.87
Jan 22	15.32
Jan 22	15.47
Jan 22	16.59
Dec 21	16.69
Dec 21	17.93
Dec 21	17.81
Dec 21	15.02
Dec 21	15.54
Nov 21	15.76
Nov 21	16.21
Nov 21	16.88
Nov 21	15.28
Oct 21	15.44
Oct 21	15.42
Oct 21	16.03
Oct 21	16.46
Oct 21	16.78
Sep 21	15.96
Sep 21	14.53
Sep 21	15.24

Price to Book

EGRX Price to Book by quarter
Period	Price to Book
Sep 26	0.01
Sep 26	0.04
Aug 26	0.05
Aug 26	0.03
Aug 26	0.03
Aug 26	0
Jul 26	0.02
Jul 26	0.02
Jul 26	0.03
Jul 26	0.03
Jul 26	0.03
Jun 26	0.03
Jun 26	0.03
Jun 26	0.03
Jun 26	0.03
May 26	0.03
May 26	0.02
May 26	0.02
May 26	0.02
May 26	0.02
Apr 26	0.02
Apr 26	0.02
Apr 26	0.02
Apr 26	0.01
Mar 26	0.02
Mar 26	0
Mar 26	0.02
Mar 26	0.01
Feb 26	0.01
Feb 26	0.01
Feb 26	0.01
Feb 26	0.01
Jan 26	0.01
Jan 26	0.04
Jan 26	0.03
Jan 26	0.02
Jan 26	0.02
Dec 25	0.02
Dec 25	0.02
Dec 25	0.03
Dec 25	0.04
Nov 25	0.03
Nov 25	0.04
Nov 25	0.07
Nov 25	0.08
Oct 25	0.04
Oct 25	0.05
Oct 25	0.08
Oct 25	0.08
Oct 25	0.16
Sep 25	0.14
Sep 25	0.18
Sep 25	0.17
Sep 25	0.16
Aug 25	0.16
Aug 25	0.17
Aug 25	0.17
Aug 25	0.17
Aug 25	0.17
Jul 25	0.19
Jul 25	0.19
Jul 25	0.18
Jul 25	0.16
Jun 25	0.15
Jun 25	0.15
Jun 25	0.12
Jun 25	0.12
May 25	0.1
May 25	0.1
May 25	0.1
May 25	0.1
May 25	0.1
Apr 25	0.09
Apr 25	0.09
Apr 25	0.06
Apr 25	0.1
Mar 25	0.05
Mar 25	0.08
Mar 25	0.07
Mar 25	0.04
Feb 25	0.06
Feb 25	0.08
Feb 25	0.06
Feb 25	0.05
Jan 25	0.04
Jan 25	0.05
Jan 25	0.03
Jan 25	0.03
Jan 25	0.02
Dec 24	0.03
Dec 24	0.03
Dec 24	0.04
Dec 24	0.04
Nov 24	0.04
Nov 24	0.05
Nov 24	0.03
Nov 24	0.04
Nov 24	0.03
Oct 24	0.03
Oct 24	0.05

No video analysis for this stock yet. Request one from our team.

News: EGRX

defenseworld.net · 17 Jul 2026

Galera Therapeutics (NASDAQ:GRTX) vs. Eagle Pharmaceuticals (NASDAQ:EGRX) Head to Head Review

Profitability This table compares Galera Therapeutics and Eagle Pharmaceuticals' net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Galera Therapeutics N/A N/A -99.34% Eagle Pharmaceuticals N/A N/A N/A Earnings and Valuation This table compares Galera Therapeutics and Eagle Pharmaceuticals"s top-line revenue, earnings per share and valuation. Gross

AI Analysis

Eagle Pharmaceuticals, Inc.

Video analysis: EGRX

News: EGRX

Galera Therapeutics (NASDAQ:GRTX) vs. Eagle Pharmaceuticals (NASDAQ:EGRX) Head to Head Review

Similar companies